全文获取类型
收费全文 | 7428篇 |
免费 | 30篇 |
国内免费 | 1篇 |
专业分类
电工技术 | 12篇 |
综合类 | 1篇 |
化学工业 | 249篇 |
金属工艺 | 9篇 |
机械仪表 | 30篇 |
建筑科学 | 40篇 |
矿业工程 | 1篇 |
能源动力 | 22篇 |
轻工业 | 114篇 |
水利工程 | 4篇 |
石油天然气 | 4篇 |
无线电 | 85篇 |
一般工业技术 | 149篇 |
冶金工业 | 6599篇 |
原子能技术 | 9篇 |
自动化技术 | 131篇 |
出版年
2023年 | 11篇 |
2022年 | 9篇 |
2021年 | 21篇 |
2020年 | 15篇 |
2019年 | 23篇 |
2018年 | 31篇 |
2017年 | 17篇 |
2016年 | 17篇 |
2015年 | 15篇 |
2014年 | 26篇 |
2013年 | 57篇 |
2012年 | 27篇 |
2011年 | 42篇 |
2010年 | 35篇 |
2009年 | 39篇 |
2008年 | 40篇 |
2007年 | 48篇 |
2006年 | 32篇 |
2005年 | 32篇 |
2004年 | 27篇 |
2003年 | 48篇 |
2002年 | 21篇 |
2001年 | 17篇 |
2000年 | 24篇 |
1999年 | 232篇 |
1998年 | 2061篇 |
1997年 | 1143篇 |
1996年 | 814篇 |
1995年 | 428篇 |
1994年 | 360篇 |
1993年 | 395篇 |
1992年 | 52篇 |
1991年 | 102篇 |
1990年 | 60篇 |
1989年 | 79篇 |
1988年 | 81篇 |
1987年 | 74篇 |
1986年 | 76篇 |
1985年 | 70篇 |
1984年 | 10篇 |
1983年 | 18篇 |
1982年 | 32篇 |
1981年 | 51篇 |
1980年 | 69篇 |
1979年 | 12篇 |
1978年 | 21篇 |
1977年 | 152篇 |
1976年 | 336篇 |
1975年 | 14篇 |
1973年 | 11篇 |
排序方式: 共有7459条查询结果,搜索用时 0 毫秒
11.
Ohne Zusammenfassung 相似文献
12.
We examined the ability of anti-human recombinant interleukin-2 (hu rIL-2) monoclonal antibody DMS-1.10 to increase serum half-life of hu rIL-2, and the effect of this complex on inhibition of tumor progression in a B16-F10 murine melanoma model. In C57B1/6 mice, intravenous (i.v.) injection of DMS-1.10 premixed with 1 x 10(4) units (U) of hu rIL-2 at a 1:1 molar ratio extended serum half-life greater than 10-fold (222 min) when compared to the same dose of hu rIL-2 alone (20 min). In a murine tumor model, multiple intraperitoneal (i.p.) injections of non-neutralizing DMS-1.10 premixed with hu rIL-2 at a 5:1 molar ratio reduced the growth rate of subcutaneous (s.c.) B16-F10 tumor in C57B1/6 mice by 64% when compared to PBS and irrelevant antibody treated controls. Although similar treatment with hu rIL-2 alone reduced tumor growth rate by 46%, it was significantly less effective than the premixed treatment. Results from a flow cytometry assay confirm B16-F10 does not have IL-2 receptors, precluding direct inhibition of tumor growth by hu rIL-2 treatments. We propose that therapeutic efficacy of hu rIL-2 is improved by prolonging the in vivo half-life with an anti-IL-2 antibody, thus augmenting hu rIL-2 bioactivity and enhancing the hosts immune response against tumor. 相似文献
13.
INTRODUCTION: The aim of the study was the evaluation of the usefulness of transesophageal atrial pacing in predicting chronic oral treatment efficacy of symptomatic reciprocating supraventricular tachycardia in infants and in avoiding the risk of very dangerous recurrences at home. METHODS: We studied 13 infants (11 males, 2 females, mean age 43 +/- 31 days) with symptomatic reciprocating supraventricular tachycardia and no structural heart disease. All patients had chronic oral therapy, using the drug effective in acute i.v. somministration. Each patient was discharged when supraventricular tachycardia was not inducible with transesophageal atrial pacing after 5 half-lives of the drug used in chronic oral treatment. All patients, every 6 months, were retested with transesophageal atrial pacing alternatively during chronic oral therapy and after complete wash out. Oral therapy was stopped in each patient when supraventricular tachycardia was not inducible after the wash out. RESULTS: The number of oral treatments tested for each patient were 2 +/- 1 (range 1-5). The number of transesophageal studies performed for each patient were 4 +/- 2 (range 3-7). No patient had symptomatic episodes of supraventricular tachycardia or needed to change therapy during the follow-up. The oral treatment was stopped after the twelfth month of life in 8 patients and after the twenty-fourth in 2 others without recurrences. CONCLUSION: Transesophageal atrial pacing seems to be useful in predicting accurately and rapidly the oral treatment efficacy of supraventricular tachycardia in infants. Our protocol seems to be effective to avoid dangerous recurrences of tachycardia and to decide when we can stop therapy without risk. 相似文献
14.
15.
16.
JL Shah 《Canadian Metallurgical Quarterly》1998,53(10):1032-1033
17.
OBJECTIVES: (1) To determine whether and how outcome measurements in the ECASS trial are influenced by a shorter time window (0-3 vs. 3-6 h) between onset of symptoms and start of thrombolytic therapy using recombinant tissue plasminogen activator (rt-PA) in acute ischemic stroke. (2) To discuss the results of the ECASS 0- to 3-hour cohort with the results of the National Institute of Neurological Disorders and Stroke Study (NINDSS). DESIGN AND ANALYSIS: Analysis of the 0- to 3-hour and the 3- to 6-hour cohort in accordance with the ECASS protocol. Comparative analysis of the ECASS and NINDSS results following the NINDSS protocol using dichotomized endpoints. MAIN OUTCOME MEASURES: Primary endpoints: modified Rankin Scale, Barthel Index; secondary endpoints: combined Barthel/Rankin, long-term Scandinavian Stroke Scale, National Institutes of Health Stroke Scale, mortality at 30 and 90 days, occurrence of intracranial hemorrhage. NINDS trial endpoint: favorable outcome as defined in the NINDS trial. RESULTS: In ECASS, 87 patients were randomized within 3 h of stroke onset. Differences in favor of rt-PA treatment can be found for all primary and secondary outcome measures in the ECASS 0- to 3-hour cohort, except for mortality at day 30, which is somewhat higher in the rt-pA-treated group. However, due to the small sample size, the differences do not reach statistical significance. Early infarct signs (as defined by the ECASS protocol) are found as early as 2 h after stroke onset. Parenchymal hemorrhages are found significantly more often among rt-PA-treated patients. The results in the ECASS 0- to 3-hour cohort fit well with the results in NINDSS. CONCLUSION: Data from the 3-hour ECASS cohort support the efficacy of early thrombolytic therapy in acute hemispheric stroke patients. Comparing bleeding complications between the ECASS and NINDSS is difficult because of differences in the definition and occurrence of hemorrhagic events. 相似文献
18.
19.
X Martinet JL L'Helgouarc'h I Roche P Favoulet P Goudet P Cougard 《Canadian Metallurgical Quarterly》1998,27(30):1534-1535
According to our common medical culture, some facts are simply unquestionable, for instance La?nnec invented the stethoscope. But was he the first one? On a recent trip to Egypt we visited the temple of Kom Ombo, built prior to the roman period and renowned as a medical care center. Today, the tourist is fascinated by the magnificent hieroglyphics on the well-preserved walls testifying to significant advances in various fields of medicine including ophthalmology and gynecology. We were particularly interested by the basreliefs presenting vivid drawings of some of the first medical instruments. We easily identified curettes, scissors, a balance, forceps for dental extraction, and a surgical saw, but were captivated by two other instruments. The first one looked a lot like what La?nnec invented around 1820. The second one was amazingly similar to the instrument we use everyday, with a distal opening and flexible tubes (woven papyrus?) leading to proximal ear pieces. Our Egyptian guide was formal: the stethoscope was invented in Egypt. The scientific impact of our observations leaves something to be desired, but did make us think about the huge gap between the advancement of medical knowledge in ancient Egypt and La?nnec's (re)-invention. Exposed to a similar gap in history, what would our documents stored on CD and video tapes have to say to future touring doctors? 相似文献
20.
JL Price 《Canadian Metallurgical Quarterly》1998,3(4):35-39
In response to a university mandate and general faculty dissatisfaction with work assignments, faculty developed a faculty work load formula. The authors discuss the development of the teaching portion of the formula. Implementation of the formula and publication of teaching work loads has resulted in greater awareness of other's responsibilities, improved faculty morale, increased accountability, and a greater sense of control. Some problem areas are also discussed. 相似文献